jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Hydrocele biopsy - Large Biopsy 3-6 cm

Biopsy
image

Report in 288Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Biopsy of hydrocele sac.

₹666₹951

30% OFF

Hydrocele Biopsy - Large Biopsy 3-6 cm

  • Why is it done?
    • Primary Purpose: To obtain tissue samples from a hydrocele (abnormal fluid collection around the testicle) measuring 3-6 cm in size for histopathological examination and diagnosis of underlying pathology
    • Primary Indications: Suspicion of malignancy, persistent or recurrent hydrocele despite conservative management, unclear etiology on imaging, presence of solid components within fluid collection, abnormal appearance on ultrasound suggesting neoplastic involvement
    • Common Clinical Scenarios: Evaluation of complex hydroceles with imaging features concerning for malignancy, assessment of secondary hydroceles from testicular tumors, investigation of hydroceles unresponsive to aspiration or sclerotherapy, staging and characterization of known testicular malignancies
    • Timing: Typically performed when hydrocele has been present for more than 3 months, after ultrasound confirmation of hydrocele size and characteristics, when conservative management has failed, or when imaging raises suspicion for underlying malignancy
  • Normal Range
    • Normal Histopathological Findings: Benign mesothelial lining of tunica vaginalis, absent or minimal inflammation, no malignant cells, no evidence of tumor invasion or metastatic disease
    • Reference Standards: Benign tissue architecture, normal cellular morphology on microscopy, absence of atypia or dysplasia, negative for malignancy (reported as 'no malignancy identified')
    • Result Categories: Negative/Benign: No malignancy, normal tissue Inflammatory: Chronic inflammation, fibrosis Positive/Malignant: Evidence of malignancy present Inconclusive: Insufficient or ambiguous findings
    • Units of Measurement: Tissue sample size: 3-6 cm as specified, microscopic examination at multiple magnifications (10x, 40x, 100x), qualitative histological analysis
  • Interpretation
    • Benign Findings: Indicates primary idiopathic hydrocele or post-traumatic hydrocele; benign mesothelial proliferation; chronic inflammation without malignancy; reassuring for absence of testicular cancer or secondary malignant hydroceles; suggests conservative or surgical management appropriate
    • Inflammatory Findings: Suggests reactive/secondary hydrocele; may indicate previous infection, trauma, or surgery; chronic inflammation without malignancy; fibrosis and adhesions may be present; correlate with clinical history for etiology determination
    • Malignant Findings: Indicates primary testicular malignancy, metastatic disease to tunica vaginalis, or secondary hydrocele from systemic malignancy; requires immediate oncologic consultation; staging studies (CT, MRI) essential; treatment planning depends on tumor type, stage, and spread
    • Mesothelioma: Malignant transformation of mesothelial cells; rare but serious finding; requires immunohistochemistry for confirmation; associated with poor prognosis; multimodal treatment consideration (surgery, chemotherapy)
    • Factors Affecting Results: Specimen adequacy and proper fixation; sampling location within hydrocele; duration of hydrocele; previous interventions or treatments; patient age and immune status; presence of concurrent inflammation masking pathology
    • Clinical Significance of Patterns: Isolated benign findings: favorable prognosis with conservative management; mixed inflammatory and benign: may recur, consider surgical intervention; any malignant component: urgent oncology referral and comprehensive staging; immunohistochemistry positive results: confirms diagnosis and guides therapy selection
  • Associated Organs
    • Primary Organ System: Male reproductive/genito-urinary system; testis and epididymis; tunica vaginalis (serous membrane surrounding testicle); scrotal tissue and structures
    • Related Structures: Spermatic cord; lymphatic channels; inguinal lymph nodes; peritoneal cavity (patent processus vaginalis); associated vasculature
    • Associated Pathological Conditions: Testicular cancer (seminoma, non-seminomatous germ cell tumors) Mesothelioma of tunica vaginalis Lymphoma involving testis or scrotum Metastatic malignancy to testis Epididymitis and chronic inflammation Testicular trauma with secondary hydrocele Post-vasectomy hydrocele Cardiac cirrhosis with ascites Renal disease with fluid retention
    • Potential Complications of Abnormal Results: If malignancy confirmed: testicular loss, infertility, chemotherapy toxicity, metastatic disease progression, need for adjuvant therapy; psychological impact of cancer diagnosis; sexual dysfunction; loss of fertility options
    • Biopsy-Related Risks: Hematoma formation; infection; damage to testicular tissue or vasculature; seeding of malignant cells (though minimized with proper technique); recurrent hydrocele after biopsy; testicular atrophy if major vessels damaged; transient scrotal pain or swelling
  • Follow-up Tests
    • If Benign Findings: Clinical follow-up at 4-6 weeks post-biopsy; scrotal ultrasound to assess for complications; repeat ultrasound in 3-6 months if hydrocele persists; no additional imaging or laboratory tests required if uncomplicated; annual testicular self-examination and physical examination
    • If Malignant Findings: Urgent staging studies: CT chest, abdomen, pelvis; abdominal/pelvic MRI for better tumor characterization; serum tumor markers (AFP, beta-hCG, LDH); baseline fertility assessment and sperm banking if not already done; oncology consultation within 1-2 weeks; consideration for radical inguinal orchiectomy
    • Immunohistochemistry and Ancillary Studies: Reflex staining for suspicious findings; flow cytometry if lymphoma suspected; electron microscopy for mesothelioma confirmation; molecular testing for specific genetic markers if indicated; special stains for infectious organisms if inflammation present
    • Complementary Imaging Studies: High-resolution scrotal ultrasound with Doppler; cross-sectional imaging (CT or MRI) for metastatic disease; PET-CT for staging if malignancy confirmed; bone scan if skeletal metastases suspected
    • Laboratory Tests: Serum tumor markers (AFP, hCG, LDH) at baseline and post-treatment; complete blood count; comprehensive metabolic panel; coagulation studies; testicular biopsy of contralateral testicle if indicated for bilateral disease assessment
    • Monitoring Frequency: Benign: Clinical exam every 6-12 months; imaging as clinically indicated. Malignant: Intensive follow-up during treatment phase (monthly); post-treatment surveillance per oncologic protocol (varies by stage and histology); long-term follow-up continues 5 years minimum, some cancers require lifelong monitoring
  • Fasting Required?
    • Fasting Required: No - Fasting is not required for hydrocele biopsy; this is a tissue biopsy procedure with local anesthesia
    • Pre-Procedure Preparation: Normal breakfast/lunch may be consumed prior to procedure; maintain normal hydration; wear comfortable, loose-fitting underwear and clothing; avoid strenuous activity 24 hours before biopsy; empty bladder before procedure
    • Medications to Avoid: Discontinue anticoagulants (warfarin, DOACs) per provider instructions (typically 3-5 days before); stop aspirin, NSAIDs, and other antiplatelet agents 5-7 days prior; avoid herbal supplements (ginkgo, ginger, garlic) 7 days before; hold medications as directed if general anesthesia planned; continue essential cardiac or hypertension medications unless specifically instructed otherwise
    • Special Instructions: Clean the genital area with mild soap and water morning of procedure; trim pubic hair if excessive; do not shave scrotum (clipping preferred); arrange transportation if sedation used; obtain informed consent and clarify risks/benefits; report fever, recent infections, or immunosuppression to provider
    • Post-Procedure Guidelines: Apply ice packs for first 48 hours (15 minutes on, 15 minutes off); wear supportive scrotal support/jockstrap for 1 week; avoid strenuous activity and heavy lifting for 2 weeks; no sexual activity for 5-7 days; mild analgesics (acetaminophen) for pain management; prophylactic antibiotics per provider instructions; report signs of infection (increasing redness, warmth, drainage, fever)

How our test process works!

customers
customers